Current filters:  
India
Food and Drugs Law
India
Singh & Associates
This segment of the newsletter focuses on sharing the recent regulatory reforms and updates on Healthcare and Pharmaceutical domain from World Health Organization (WHO).
Singh & Associates
Ayurveda, Yoga, Unani, Siddha and Homeopathy (AYUSH) - the traditional systems of medicine play a crucial role in public health in India.
Singh & Associates
Antimicrobial resistance (AMR) is a broad term for resistance in different types of microorganisms such as bacteria, viruses, fungi and parasites, to antibiotics such as...
Singh & Associates
The Central Drugs Standard Control Organization (CDSCO), New Delhi, under the aegis of the Ministry of Health ...
Nishith Desai Associates
While there has been some significant development in the healthcare sector (specifically in the area of regulating doctors), medical devices sector has clearly witnessed the largest number of developments this year.
Nishith Desai Associates
The last quarter of 2019 has been more about beginnings rather than endings. The hot button issue of e-pharmacy regulation has made a comeback to the forefront of regulatory discourse while a new issue
S.S. Rana & Co. Advocates
The Lok Sabha passed The Prohibition of Electronic Cigarettes (Production, Manufacture, Import, Export, Transport, Sale, Distribution, Storage and Advertisement) Bill, 2019 on 27 November 2019 seeking the prohibition ...
S.S. Rana & Co. Advocates
The legislative framework in India aims to ensure standardization based on scientific principles regulating their manufacture, storage, distribution, sale and import of items for safe human consumption.
Gopakumar Nair Associates
It is my pleasure and privilege to commence this "Editorial" feature in "Indian Drugs", as proposed by our Publication Committee and the Editorial Board.
Nishith Desai Associates
The Ministry of Health and Family Welfare has released two draft notifications to regulate all medical devices in India under the Medical Device Rules, 2017.
S.S. Rana & Co. Advocates
The Government of India had published draft rules and invited comments/suggestions from the consumers/stakeholders for amending the Drug and Cosmetic Rules, 1945.
Singh & Associates
On July 15, 2019, Indian Council of Medical Research (ICMR) has launched a vaccine trial (‘Trial') to prevent the occurrence of Tuberculosis (TB) among close contacts of TB patients.
Singh & Associates
Variation in chemicals produce known and unknown toxicity which raises red flags about the safety and efficacy of this system.
Singh & Associates
The labelling requirement will not directly affect the quality, safety and efficacy of drug products.
Singh & Associates
. Out of this, an amount of INR 5.56 crore has been recovered and demand notices amounting to INR 89.31 crore are under litigation.
Singh & Associates
This segment of the newsletter shares recent information associated with regulatory reforms from Healthcare and Pharmaceutical sectors from in Indian jurisdiction.
Singh & Associates
This segment discusses the recent drug approvals from the US FDA in various severe diseases. The write-ups describe the role of a new drug in the treatment of serious conditions such as myeloma
Singh & Associates
This segment of the newsletter is focused on sharing the recent regulatory reforms and updates on Healthcare and Pharmaceutical domain from the World Health Organization (WHO).
Singh & Associates
On July 10, 2019, Indian Pharmacopoeia Commission declared that the Government of Ghana has given recognition to the Indian pharmacopoeia after continuous efforts of Central government in achieving the recognition
Singh & Associates
In order to increase the efficacy and role of herbal products in treating the prioritized diseases, the AYUSH ministry will fund research projects for the year 2019 in non-communicable disease...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media